Efficacy of ChiroRab™

Phase IV study to evaluate the efficacy in terms of 1-year survival with ChiroRab™ administered intradermally in subjects exposed to laboratory confirmed rabid animals has shown that 12 months after exposure, all 113 patients  were alive and no patient had succumbed to rabies or died of other causes.1

Reference:

1.Quiambao BP, et al. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals. Vaccine. 2005;23(14):1709-14.